Axsome Therapeutics Inc <AXSM.O>: BMO initiates coverage with outperform rating; target price $310
AXSM•Related News
Non-competitive bids for U.S. 6-week bills
TLT•
Nasdaq trade halt continues <OST.O> reason not available at 11:50 AM
OST•
Apple to launch 'Upgrade' device leasing program to spur sales, Bloomberg News reports
AAPL•
Cushman & Wakefield names Chris Sonne executive director in valuation advisory return
CWK•
From Australia to Europe, countries move to curb children's social media access
XLC•